The document provides an overview of approach to anemia in children. It begins with definitions of anemia and discusses clinical features and etiologies. Common causes of anemia include impaired red blood cell production, increased red blood cell destruction, and blood loss. The document reviews physiological neonatal anemia and pathological neonatal anemia. It outlines the clinical approach including history, physical exam, and initial lab workup. The approach depends on red blood cell indices and reticulocyte count to guide further testing and diagnosis of the underlying cause.
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
Interactive talk on common hematological and oncological emergencies - which if not noticed early can lead to irreversible complications and death .
Intended to be used for educational purposes for the fertile minds in medicine .
This presentation focuses on a recently published paper aiming to create an algorithm for the investigation of patients with new onset fever or instability
This presentation covers some nephrology radiology cases taken from MRCPCH exam books. The aim is to understand and be able to recognize basic pediatric nephrology radiologic images in order to succeed in exam settings and have an upper hand in clinical work.
Pediatric Screen Time Review - Journal Club Fatima Farid
Journal club session - review of a study conducted on the effects of screen time on a pediatric population, includes effective paper reviewing strategies.
Complicated Pediatric Pneumococcal Meningitis - Case PresentationFatima Farid
A unique case report of pneumococcal meningitis complicated by diffuse vasculitis and severe neurologic debility. Child displayed remarkable recovery with steroid therapy despite prolonged severe disease course!
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
3. Definition
» “Anemia is defined as a reduction of the hemoglobin concentration or red blood cell
(RBC) volume below the range of values occurring in healthy persons”, Nelson
Textbook of Pediatrics, 20th Edition.
» Practically, the threshold for defining anemia is a hemoglobin or hematocrit value at
or below the 2.5th percentile for age, race and gender. UpToDate, 2017
» Anemia should not be considered a diagnosis, but rather a finding that warrants
further investigation.
4. Clinical Features
» Anemia may manifest clearly if developed acutely, or with minimal features if
chronically present.
» Common manifestations of anemia:
» Pallor
» Lethargy, easy fatiguability
» Poor feeding/ exercise intolerance
» Irritability
» Headache
5. Etiology
» Anemia is not a specific entity, but rather a manifestation of any number of underlying
pathological processes.
» Underlying conditions may be classified as:
» Inadequate production of red blood cells
» Increased destruction of red blood cells
» Blood loss
» Physiologically, anemia can even be present with normal hemoglobin concentrations,
such as in congenital cyanotic heart disease, pulmonary disease and conditions with
abnormally hemoglobin affinity for oxygen.
7. Impaired Red Cell Production
» Red Cell Aplasia:
» Parvovirus B19 Infection: It is the best documented viral cause of RBC aplasia in patients with
chronic hemolysis, immunocompromised states, or fetuses in- utero. Virus is toxic to marrow
erythroid progenitor cells.
» Diamond- Blackfan Anemia: Rare congenital bone marrow failure syndrome. Autosomal dominant
inheritance. More than 90% of cases are diagnosed in the first year of life. Present with profound
anemia at 2- 6 months of age. Approximately 50% of patients have congenital anomalies. Raised
erythrocyte adenosine deaminase (ADA) is characteristic.
» Transient Erythroblastopenia of Childhood (TEC): Most common acquired red cell aplasia.
Moderate to severe normocytic anemia with reticulocytopenia following viral infection in a
previously healthy child (aged 6 months to 3 years, usually older than 12 months). Recovery in 1- 2
months. Child must be followed closely to rule out Leukemia.
8. Impaired Red Cell Production
» Ineffective Erythropoiesis:
» Iron deficiency: Presents after 6- 9 months of age (after neonatal stores depleted). May be due in
inadequate intake (cow milk- iron deficient, milk protein allergic colitis), chronic bleeding (peptic
ulcer, Meckel diverticulum, polyp, hemangioma, IBD, parasitic infections, menstruation), or poor
absorption (Celiac disease, Giardiasis).
» Folic Acid deficiency: Inadequate intake (goat milk), increased requirements (chronic hemolysis,
premature babies), poor absorption (chronic diarrhea, diffuse bowel inflammatory disease), drugs
(Methotrexate, Pyrimethamine, Trimethoprim), inborn error of folic acid metabolism (severe
brain affliction).
9. Impaired Red Cell Production
» Ineffective Erythropoiesis:
» Chronic diseases with on- going immune activation:
» Shortened RBC life-span (high IL- 1 makes macrophages more active)
» Ineffective erythropoiesis due to effect of immune cells/ cytokines on BM
» Functional iron deficiency due to raised Hepcidin (diverts iron from circulation into RES
despite low circulatory concentration)
» Anemia of chronic kidney disease: Impaired erythropoietin production and chronic
blood loss (blood sampling, dialysis)
12. Hemolysis
» Hereditary Spherocytosis: Mainly autosomal dominant inheritance. Affected patients
may be asymptomatic with minimal anemia/ hemolysis, or have severe disease
requiring regular blood transfusions and splenectomy. Significant cause of neonatal
anemia and jaundice requiring phototherapy or even exchange transfusion.
Splenomegaly is common after infancy, gall stones may develop. Diagnostic triad is
anemia, jaundice and splenomegaly, with spherocytes on blood film, reticulocytosis,
elevated MCHC, and suggestive family history.
13. Hemolysis
» G6PDD: X- linked inheritance. Asymptomatic till exposure to triggering agent, resulting
in rapid drop in hemoglobin, jaundice, dark urine. May present in neonates at birth in
case of maternal exposure, or if a certain genetic variant is present (G6PD A-, G6PD B-).
Diagnosed by enzyme activity ≤ 10%.
» Thalassemia: Spectrum of presentations depending on severity of condition. Diagnosed
by hemoglobin electrophoresis. Microcytic hypochromic anemia with normal/ high RDW.
» Autoimmune Hemolytic Anemia: Warm and cold types several underlying conditions.
May present acutely similar to HS, distinguished as AIHA is DAT positive.
16. * The production of androgens at the onset of puberty in boys causes males to maintain a normal hemoglobin
value about 1.5 to 2 g/dL higher than girls. Menstruation also plays a role in lower hemoglobin levels in post-
menarchal girls.
*
*
Source: Approach to the child with anemia, UpToDate
18. Physiological Anemia
» Healthy full- term infants have high hemoglobin concentrations, and larger RBC
volumes than to older children and adults.
» Within the first week of life, a progressive decline in hemoglobin concentration begins
and then persists for six to eight weeks.
» The hemoglobin concentration continues to decline until the tissue oxygen needs exceed
the oxygen delivery. This point usually occurs between 8 to 12 weeks, when a
physiological nadir of 11 g/dL is reached.
19. Physiological Anemia
» Represents the normal adaptation to extra- uterine life, and reflects the relative
excess of oxygen supply compared to tissue requirements.
» The is no hematologic problem, and no treatment is required unless anemia is
exacerbated by other ongoing processes.
21. Anemia of Prematurity
» The same physiological factors at play in term infants are exaggerated in prematurity.
» Hemoglobin decline is more severe and rapid, nadir is at 7- 8 g/dL at 3- 6 weeks of age,
and may be even lower in very small premature babies.
» Additionally, over- burdened erythropoiesis: shorter RBC life span with larger mass,
immature erythropoietin production.
» Not a benign condition, and may require blood transfusion.
22. Case: Neonatal Anemia
» A full- term infant is delivered with the use of forceps; the pregnancy and
delivery were otherwise uncomplicated.
The initial examination is normal, but on the second hospital day, he is pale
and fussy. The reticulocyte count and bilirubin level are normal, and the
hemoglobin is 9 g/dL. Repeat physical examination reveals an increased head
circumference.
Source: Evaluation of Anemia in Children, American Association of Family Physicians, Journal, Volume 81, Number 12, June 2010
23. Neonatal Anemia
» Pathological anemia in newborns and infants is distinguished from physiological anemia
by the presence of any one of the following:
1. Hemoglobin less than 13.5 g/dL in the first month of life
2. Anemia with lower hemoglobin levels than typically seen in physiological anemia (< 9 g/dL)
3. Signs of hemolysis or symptoms of anemia
» Common causes of pathological anemia in newborns include blood loss, immune
hemolytic disease, congenital infection, congenital hemolytic anemia, and twin- to- twin
transfusion syndrome.
24. Case: Neonatal Anemia
» Cranial hemorrhages are often associated with birth trauma, including vacuum and forceps
delivery. In particular, subgaleal bleeds (sub-aponeurotic hemorrhage) can be of sufficient
volume to cause shock. Physical examination findings may include mental status changes,
jaundice, tachycardia or tachypnea, and increased head circumference.
» In this patient, a computed tomography scan confirms a subgaleal hemorrhage, and the
infant is transferred to a neonatal intensive care unit for transfusion and monitoring.
Source: Evaluation of Anemia in Children, American Association of Family Physicians, Journal, Volume 81, Number 12, June 2010
25. Source: Evaluation of Anemia in Children, American Association of Family Physicians, Journal, Volume 81, Number 12, June 2010
30. History
» Characterizing the symptoms helps elucidate the severity and chronicity of anemia,
and may identify patients with blood loss or hemolytic etiologies.
1. Onset and severity of symptoms: lethargy, pallor, poor oral intake, irritability
2. Symptoms of hemolysis: jaundice, darkening in urine
3. Bleeding symptoms: changes in stool colour (black, or with frank blood), bowel habits, severe/
chronic epistaxis, detailed menstrual history
4. Systemic review to detect underlying medical condition
31. History
» Past Medical History:
1. Previous diagnosis of anemia: features, cause, treatment nature and duration, resolution.
Review previous blood investigations if possible.
2. Recent infectious illness
3. Known medical disease
» Dietary History:
1. Type and amount of food/ formula/ milk
2. Age when breast feeding/ formula milk was discontinued
3. Dietary habits, including presence of pica
32. History
» Birth History:
1. Gestational age
2. Duration of birth hospitalization
3. Jaundice or pallor at birth
4. Reports of neonatal screening
» Developmental History: Age- appropriate milestones
» Drug History:
1. Current and past medications, including herbal/ homeopathic therapy, Phenytoin
2. Recent antibiotic use (immune- mediated hemolysis with Penicillin)
3. Specifically ask about drugs known to precipitate hemolytic episodes in G6PDD
33. History
» Family History:
1. Diagnosed hematological diseases
2. Jaundice/ dark urine after food/ medicine affecting only male members of family
3. History of cholecystectomy or splenectomy
4. Bleeding disorders (von Willebrand disease, Hemophilia, etc)
5. Inflammatory bowel disease, colorectal cancer, intestinal polyps
» Recent infectious exposure/ travel abroad
» Social History: primary care- giver, housing and living condition
Source: Nelson Essentials of Pediatrics, Seventh Edition
34. Physical Examination
» General examination with growth chart assessment.
» Head: cephalohematoma, sub-aponeurotic hemorrhage, frontal bossing with prominence of malar
and maxillary bones
» Skin: pallor, jaundice, petechia/ bruising
» Mouth: glossitis, angular stomatitis, cleft lip, telangiectasia
» Chest: shield- shaped chest, unilateral absence of pectoral muscle, murmur
» Abdomen: organomegaly, perineal exam for hemorrhoids
» Extremities: spoon nails, triphalangeal thumb, hypoplasia of thenar eminence, Beau’s lines
» CNS: irritability/ apathy, peripheral neuropathy, ataxia, stroke
35.
36. Investigations
» Initial blood work- up should include:
1. Complete blood count: hemoglobin level, red cell indices (MCV, MCH, MCHC, RDW),
Hematocrit, WBC/ platelet counts.
2. Peripheral blood film
3. Reticulocyte count
1. Absolute Reticulocyte Count (ARC) : Value < 100 x 10^9 /L means an inadequate BM response.
2. Reticulocyte Production Index (RPI): Value < 2 means an inadequate BM response
» Further work-up depends on suspected underlying causes.
47. Conclusion
» The threshold for defining anemia is hemoglobin or hematocrit concentration less than or equal
to the 2.5th percentile for age, gender and race. Physiological anemia of infancy involves a rapid
decline in hemoglobin to around 11 g/dL at 6- 9 weeks of age.
» Labs include a complete blood count, including RBC indices, reticulocyte count, and review of the
peripheral blood smear. Examination of the peripheral blood smear may reveal features that
suggest a specific cause of anemia, and helps to evaluate the possibility of a hematologic
malignancy.
» The MCV provides a preliminary categorization of the anemia, which guides additional testing.
Source: Approach to the child with anemia, UpToDate
48. Conclusion
» The reticulocyte count distinguishes disorders resulting from rapid destruction or loss
of RBCs (hemolysis or bleeding) from disorders resulting in an inability to adequately
produce RBCs (ie, bone marrow depression). Hemolysis and bleeding are usually
associated with a high reticulocyte count (>3 percent), whereas bone marrow
depression is associated with a low reticulocyte count.
» Once the diagnostic possibilities have been narrowed based upon RBC indices and
reticulocyte response, further confirmatory testing is performed.
Source: Approach to the child with anemia, UpToDate
49. References
» Nelson Textbook of Pediatrics, Twentieth Edition
» Nelson Essentials of Pediatrics, Seventh Edition
» Illustrated Textbook of Pediatrics, Fifth Edition
» “Approach to the child with anemia”, UpToDate
» Evaluation of Anemia in Children, American Association of Family Physicians,
Journal, Volume 81, Number 12, June 2010
» 100 Cases in Pediatrics, 2009 Edition